In Episode 1, Part 1, Jon Hamrick, Rena Goins and Bob Cochran discuss how 340B, the IRA, specialty therapies and launch planning have reshaped the role of commercial trade.
Executive Conversations: Has Commercial Trade Become Pharma's Strategic Engine?
In Episode 1, Part 2, Jon Hamrick, Bob Cochran and Rena Goins explain why trade belongs in commercial planning at least a year before launch.
In Episode 1, Part 3, Jon Hamrick, Rena Goins and Bob Cochran explain why specialty networks should start small and how to balance access, data and support.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Lilly and Hims & Hers Team Up, Swisslog Expands Tenutō Cold Storage
2
CVS Health’s Breakup: A Turning Point for Pharma Supply Chains or a Redistribution of Market Power?
3
Why the Next Wave of Drug Launches Will Be Won on Market Access
4
Executive Conversations: Why Specialty Drug Networks Should Start Small
5